TrialCancer2013

Results of inotuzumab ozogamicin, a CD22 monoclonal antibody, in refractory and relapsed acute lymphocytic leukemia.

Hagop Kantarjian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.